Search

December 15, 2023, Inside Medical Liability
MPL Cases: What Are the Primary Drivers of High-Indemnity Medical Malpractice Claims?
Jacqueline Ross, RN, PhD, Coding Director, and Kathrine Soulsby, RN, BSN, Senior Patient Safety Analyst, The Doctors Company, part of TDC Group, investigate high-dollar medical malpractice litigation and explain how reducing diagnostic errors is paramount to enhancing patient safety and mitigating loss costs.

Oct 19, 2023
Interventional Radiology Wrong-Site Procedure: Case Review
Julie Song, MPH, CPHRM, Patient Safety Risk Manager II, The Doctors Company
This case review explores factors contributing to a wrong-site procedure and highlights strategies that can help practitioners mitigate risk and increase safety.

Jun 15, 2020
Overview of Obesity-Related Malpractice Claims
Paul Nagle, ARM, CPHRM, Director, Department of Patient Safety and Risk Management
The Doctors Company continues to see an increase in lawsuits involving patients with obesity.

February 23, 2023, Today's Hospitalist
The Pandemic’s Impact on Malpractice Claims
Peter Kolbert, JD, Senior Vice President, Claim & Litigation Services, Healthcare Risk Advisors (HRA), part of TDC Group, discusses the impact the pandemic had on malpractice claims as we approach the third anniversary of COVID-19.

January 27, 2022, Medscape
Medscape Psychiatrist Malpractice Report 2021
Peter Kolbert, JD, Senior Vice President of Claim and Litigation Services for Healthcare Risk Advisors, part of TDC Group, is quoted on why many psychiatrists have not reported being sued for a COVID-19–related allegation.

January 27, 2022, Medscape
Medscape Orthopedist Malpractice Report 2021
Peter Kolbert, JD, Senior Vice President of Claim and Litigation Services for Healthcare Risk Advisors, part of TDC Group, is among experts quoted on why orthopedists face malpractice lawsuits.

Professional Education
Alzheimer's 5 : Use of Pharmacotherapy for Patients with Major Neurocognitive Disorder
This activity includes video lectures and is the fifth in a series of courses that seek to educate clinicians on standardized screening, evaluation, and disease management of Alzheimer's disease and related dementias. This fifth course focuses on the most frequently used and FDA-approved prescription medications for Alzheimer's disease and dementias, the current research regarding its use, and guidelines for prescribing and discontinuing medication. The program will incorporate cultural values and beliefs when creating and sharing the pharmacological care plan. [1.75 AMA PRA Category 1 Credits™, 1.75 Contact Hours (ANCC)]

Stay in the Know

Sign up for The Doctor’s Practice.

Our e-newsletter features timely articles, videos, and guides on a range of patient safety topics.

Subscribe